Day-and-night hybrid closed-loop insulin delivery improves glucose control compared with sensor-augmented pump therapy.
Researchers found that patients with T1DM and poor glycemic control were more frequently diagnosed with infections.
Investigators examined renal outcomes when controlling cardiovascular risk factors, such as blood pressure, LDL-C, and HbA1c.
The safety assessment included incidence of insertion or procedure-related removal and device-related serious adverse events through 180 after insertion.
MEDI0382 reduced body weight and normalized fasting and postprandial blood glucose levels in patients with type 2 diabetes.
The ITCA 650, a small titanium osmotic mini-pump, provides a subcutaneous infusion of exenatide over 3 or 6 months.
The American Diabetes Association (ADA) has released a public policy statement that outlines long- and short-term recommendations for improving insulin affordability.
ACP responds to criticism from the ADA, the Endocrine Society, the AACE, and the AADE of guidance that clinicians should aim to achieve an HbA1c level between 7% and 8% in most people with type 2 diabetes.
The American College of Physicians has developed recommendation statements to guide clinicians in selecting targets for pharmacologic treatment of type 2 diabetes.
The FDA has approved semaglutide injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Primary care referral to Weight Watchers meetings is associated with weight loss, HbA1c reduction.
The system uses a small sensor implanted below the skin and a mobile reader to continuously monitor blood glucose.
Lifestyle interventions maintain glycemic control in patients with type 2 diabetes.
The CPAP group had a larger decrease in HbA1c levels after 6 months.
Eating more potatoes before pregnancy may be associated with greater risk of gestational diabetes mellitus,
A patient with diabetes questions the necessity of starting a statin.
The glycated hemoglobin in the intensive control group was 6.9%, on average. For those on standard care, the glycated hemoglobin average was 8.4%.
A majority of patients with diabetes are worried about experiencing hypoglycemia, with many being uncertain about how to manage the condition.
Lack of confidence when mobilizing and hypoglycemia in an elderly lady with type 2 diabetes.
Better glycemic control, lower medication use among obese patients with diabetes who undergo bariatric surgery.
The FDA has approved Nesina, Oseni, and Kazano as adjuncts to diet and exercise for treating adults with type 2 diabetes.
Encouraging patients with type 2 diabetes to incorporate legumes into their diet may help improve glycemic control, lower coronary heart disease risk.
Two clinicians disagree on a diagnosis after reviewing two-hour oral glucose tolerance test results. Who is correct?
A patient with newly diagnosed diabetes has a hemoglobin (Hb) A1c of 12.2% and glucose 350 mg/dL, despite increasing insulin (glargine [Lantus]) to 25 units. What else can be done to lower blood sugar?
The FDA has approved a new insulin pump system -- Roche's Accu-Chek Combo -- that combines a blood glucose meter and insulin pump, which exchange information using Bluetooth technology.
Patients with prediabetes who achieve normal glucose regulation, even just one time, have a lower risk for progressing to diabetes.
Risk of death at 90 days up for pneumonia patients without preexisting diabetes who present with hyperglycemia.
Rosiglitazone plus metformin beat metformin alone or lifestyle interventions in adolescents with type 2 diabetes.
Jentadueto is an oral formulation of linagliptin and metformin indicated as an adjunct therapy to diet and exercise for treating type 2 diabetes.
The benefits of tight glycemic control may not outweigh the risks among premature infants with hyperglycemia, results of a randomized clinical trial suggest.